Current Status of Allograft Tolerance in Intestinal Transplantation

REFERENCES

• Fishbein TM. Intestinal transplantation. N Engl J Med 2009;361(10):998–1008.
   PubMed Web of Science ®Google Scholar
• Selvaggi G, Tzakis AG. Small bowel transplantation: technical advances/updates. Curr Opin Organ Transplant 2009;14(3):262–266.
   Google Scholar
• Ueno T, Fukuzawa M. Current status of intestinal transplantation. Surg Today 2010;40(12): 1112–1122.
   Google Scholar
• Fishbein TM, Gondolesi GE, Kaufman SS. Intestinal transplantation for gut failure. Gastroenterology 2003;124(6):1615–1628.
   Google Scholar
• Abu-Elmagd KM, Costa G, Bond GJ, Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int 2009;22(1):96–109.
   Google Scholar
• Starzl TE, Murase N, Abu-Elmagd K, Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361(9368):1502–1510.
   Google Scholar
• Newell KA. Clinical transplantation tolerance. Semin Immunopathol 2011;33(2):91–104.
   Google Scholar
• Owens ML, Maxwell JG, Goodnight J, Wolcott MW. Discontinuance of immunosuprression in renal transplant patients. Arch Surg 1975;110(12):1450–1451.
   Google Scholar
• Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953;172(4379):603–606.
   PubMed Web of Science ®Google Scholar
• Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol 2013;13(1):23–33.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005;19(7):681–693.
   PubMed Web of Science ®Google Scholar
• Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008;29(3):125–132.
   PubMed Web of Science ®Google Scholar
• Carosella ED. The tolerogenic molecule HLA-G. Immunol Lett 2011;138(1):22–24.
   PubMed Web of Science ®Google Scholar
• Lila N, Amrein C, Guillemain R, Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002;105(16):1949–1954.
   PubMed Web of Science ®Google Scholar
• Crispim JC, Duarte RA, Soares CP, Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008;18(4):361–367.
   Google Scholar
• Creput C, Le Friec G, Bahri R, Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol 2003;64(11):1033–1038.
   Google Scholar
• Zarkhin V, Talisetti A, Li L, Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation 2010;90(9):1000–1005.
   PubMed Web of Science ®Google Scholar
• Castellaneta A, Mazariegos GV, Nayyar N, HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance. Transplantation 2011;91(10):1132–1140.
   PubMed Web of Science ®Google Scholar
• Griesemer AD, Sorenson EC, Hardy MA. The role of the thymus in tolerance. Transplantation 2010;90(5):465–474.
   Google Scholar
• Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 1990;248(4961):1342–1348.
   Google Scholar
• Naji A. Induction of tolerance by intrathymic inoculation of alloantigen. Curr Opin Immunol 1996;8(5):704–709.
   Google Scholar
• Miller JF, Morahan G. Peripheral T cell tolerance. Annu Rev Immunol 1992;10:51–69.
   PubMed Web of Science ®Google Scholar
• Xing Y, Hogquist KA. T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol 2012;4(6):a006957.
   PubMed Web of Science ®Google Scholar
• Chappert P, Schwartz RH. Induction of T cell anergy: integration of environmental cues and infectious tolerance. Curr Opin Immunol 2010;22(5):552–559.
   PubMed Web of Science ®Google Scholar
• Bilate AM, Lafaille JJ. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu Rev Immunol 2012;30:733–758.
   PubMed Web of Science ®Google Scholar
• Ezzelarab M, Thomson AW. Tolerogenic dendritic cells and their role in transplantation. Semin Immunol 2011;23(4):252–263.
   PubMed Web of Science ®Google Scholar
• Sordi V, Piemonti L. Therapeutic plasticity of stem cells and allograft tolerance. Cytotherapy 2011;13(6):647–660.
   PubMed Web of Science ®Google Scholar
• Shalev I, Selzner N, Shyu W, Role of regulatory T cells in the promotion of transplant tolerance. Liver Transpl 2012;18(7):761–770.
   PubMedGoogle Scholar
• Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012;12(6):417–430.
   PubMed Web of Science ®Google Scholar
• Coelho V, Saitovitch D, Kalil J, Silva HM. Rethinking the multiple roles of B cells in organ transplantation. Curr Opin Organ Transplant 2013;18(1):13–21.
   Google Scholar
• Priyadharshini B, Greiner DL, Brehm MA. T-cell activation and transplantation tolerance. Transplant Rev (Orlando) 2012;26(3):212–222.
   Google Scholar
• Newell KA, He G, Guo Z, Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol 1999;163(5):2358–2362.
   Google Scholar
• Meng L, Guo Z, Kim O, Blockade of the CD40 pathway fails to prevent CD8 T cell-mediated intestinal allograft rejection. Transplant Proc 2001;33(1–2):418–420.
   Google Scholar
• Wolf D, Schreiber TH, Tryphonopoulos P, Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival. Transplantation 2012;94(6):569–574.
   PubMedGoogle Scholar
• Abe Y, Urakami H, Ostanin D, Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts. PLoS One 2009;4(11):e7840.
   Google Scholar
• Bestard O, Cassis L, Cruzado JM, Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation. Transpl Int 2011;24(5):451–460.
   PubMedGoogle Scholar
• Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011;241(1):241–259.
   PubMedGoogle Scholar
• Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol 2012;5(3):232–239.
   PubMed Web of Science ®Google Scholar
• Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994;91(14):6688–6692.
   PubMed Web of Science ®Google Scholar
• Chen Y, Inobe J, Marks R, Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376(6536):177–180.
   PubMed Web of Science ®Google Scholar
• Chen Y, Inobe J, Kuchroo VK, Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996;93(1):388–391.
   Google Scholar
• Siewert C, Lauer U, Cording S, Experience-driven development: effector/memory-like alphaE+Foxp3+ regulatory T cells originate from both naive T cells and naturally occurring naive-like regulatory T cells. J Immunol 2008;180(1):146–155.
   Google Scholar
• Chen Y, Kuchroo VK, Inobe J, Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265(5176):1237–1240.
   PubMed Web of Science ®Google Scholar
• Groux H, O'Garra A, Bigler M, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389(6652):737–742.
   PubMed Web of Science ®Google Scholar
• Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009;30(5):626–635.
   PubMed Web of Science ®Google Scholar
• Milling S, Yrlid U, Cerovic V, MacPherson G. Subsets of migrating intestinal dendritic cells. Immunol Rev 2010;234(1):259–267.
   Google Scholar
• Womer KL, Magee CC, Najafian N, A pilot study on the immunological effects of oral administration of donor major histocompatibility complex class II peptides in renal transplant recipients. Clin Transplant 2008;22(6):754–759.
   Google Scholar
• Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3(4):331–341.
   PubMed Web of Science ®Google Scholar
• Zoller KM, Cho SI, Cohen JJ, Harrington JT. Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int 1980;18(1):110–114.
   Google Scholar
• Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 2006;6(8):1774–1780.
   PubMed Web of Science ®Google Scholar
• Ashton-Chess J, Giral M, Brouard S, Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 2007;84(10):1215–1219.
   Google Scholar
• Berney T, Genton L, Buhler LH, Five-year follow-up after pediatric living related small bowel transplantation between two monozygotic twins. Transplant Proc 2004;36(2):316–318.
   Google Scholar
• Pallier A, Hillion S, Danger R, Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010;78(5):503–513.
   PubMed Web of Science ®Google Scholar
• Braza F, Soulillou JP, Brouard S. Gene expression signature in transplantation tolerance. Clin Chim Acta 2012;413(17–18):1414–1418.
   Google Scholar
• Danger R, Pallier A, Giral M, Upregulation of miR-142–3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol 2012;23(4):597–606.
   PubMed Web of Science ®Google Scholar
• Mazariegos GV, Zahorchak AF, Reyes J, Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 2003;3(6):689–696.
   PubMed Web of Science ®Google Scholar
• Pons JA, Revilla-Nuin B, Baroja-Mazo A, FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation. 2008;86(10):1370–1378.
   PubMed Web of Science ®Google Scholar
• Martinez-Llordella M, Puig-Pey I, Orlando G, Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007;7(2):309–319.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhu L, Quan D, Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996;62(9):1267–12672.
   Google Scholar
• Murase N, Ye Q, Nalesnik MA, Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 2000;70(11):1632–1641.
   Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454(7203):428–435.
   PubMed Web of Science ®Google Scholar
• Schenten D, Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv Immunol 2011;109:87–124.
   PubMed Web of Science ®Google Scholar
• Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012;37(4):601–610.
   PubMed Web of Science ®Google Scholar
• Hirsiger S, Simmen HP, Werner CM, Danger signals activating the immune response after trauma. Mediators Inflamm 2012;2012:315941.
   PubMed Web of Science ®Google Scholar
• Liu W, Li XC. An overview on non-T cell pathways in transplant rejection and tolerance. Curr Opin Organ Transplant 2010;15(4):422–426.
   Google Scholar
• Murphy SP, Porrett PM, Turka LA. Innate immunity in transplant tolerance and rejection. Immunol Rev 2011;241(1):39–48.
   Google Scholar
• Eltzschig HK, Eckle T. Ischemia and reperfusion—from mechanism to translation. Nat Med 2011;17(11):1391–1401.
   PubMed Web of Science ®Google Scholar
• Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemia–reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004;49(9):1359–1377.
   PubMed Web of Science ®Google Scholar
• Lausada N, Stringa P, Cabanne A, [Impact of ischemia–reperfusion injury on long survival rate in intestinal transplantation in rats]. Acta Gastroenterol Latinoam 2011;41(2):129–136.
   Google Scholar
• Stringa P, Lausada N, Romanin D, Defining the nonreturn time for intestinal ischemia reperfusion injury in mice. Transplant Proc 2012;44(5):1214–1217.
   Google Scholar
• Kawai M, Kitade H, Koshiba T, Intestinal ischemia reperfusion and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection. Transplantation 2009;87(10):1464–1467.
   Google Scholar
• Pirenne J, Kawai M. Intestinal transplantation: evolution in immunosuppression protocols. Curr Opin Organ Transplant 2009;14(3):250–255.
   Google Scholar
• Watson MJ, Ke B, Shen XD, Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice. Surgery 2012;152(5):843–850.
   Google Scholar
• Oltean M, Pullerits R, Zhu C, Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats. Surgery 2007;141(5):667–677.
   Google Scholar
• Cicora F, Roberti J, Vasquez D, Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia–reperfusion injury in a rat syngenic kidney transplantation model. Clin Exp Immunol 2012;167(1):169–177.
   Google Scholar
• Farmer DG, Ke B, Shen XD, Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity. Transplantation 2011;91(7):737–743.
   Google Scholar
• Saeki I, Matsuura T, Hayashida M, Taguchi T. Ischemic preconditioning and remote ischemic preconditioning have protective effect against cold ischemia–reperfusion injury of rat small intestine. Pediatr Surg Int 2011;27(8):857–862.
   Google Scholar
• Stringa P, Romanin D, Lausada N, Ischemic preconditioning and tacrolimus pre-treatment as strategies to attenuate intestinal ischemia–reperfusion injury in mice. Transplant Proc in press.
   Google Scholar
• Newell KA, He G, Hart J, Thistlethwaite JR, Jr. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. Transplantation 1997;64(7):959–965.
   Google Scholar
• Bishop DK, Chan S, Li W, CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 1993;56(4):892–897.
   Google Scholar
• He G, Hart J, Kim OS, The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation 1999;67(1):131–137.
   Google Scholar
• Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004;25(11):570–577.
   Google Scholar
• Brandtzaeg P, Kiyono H, Pabst R, Russell MW. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 2008;1(1):31–37.
   PubMed Web of Science ®Google Scholar
• Wang J, Dong Y, Sun JZ, Donor lymphoid organs are a major site of alloreactive T-cell priming following intestinal transplantation. Am J Transplant 2006;6(11):2563–2571.
   Google Scholar
• Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 2008;28(6):740–750.
   PubMed Web of Science ®Google Scholar
• Newberry RD. Intestinal lymphoid tissues: is variety an asset or a liability? Curr Opin Gastroenterol 2008;24(2):121–128.
   Google Scholar
• Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307(5717):1920–1925.
   PubMed Web of Science ®Google Scholar
• MacDonald TT, Monteleone I, Fantini MC, Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011;140(6):1768–1775.
   PubMed Web of Science ®Google Scholar
• Schmid T, Koeroezsi G, Oberhuber G, Lymphatic regeneration after small bowel transplantation. Transplant Proc 1990;22(4):2060–2061.
   Google Scholar
• Schier F, Uner A, Waldschmidt J. Microlymphography of spontaneous lymph vessel anastomosis in small bowel transplantation in the rat. J Pediatr Surg 1991;26(10):1239–1242.
   Google Scholar
• Uner A, Weinberg AM, Nautrup CP, Spontaneous reanastomosis between lymphatic vessels following syngeneic transplantation of the small intestine in the rat. Surg Radiol Anat 2001;23(6):383–387.
   Google Scholar
• Kellersman R, Zhong R, Kiyochi H, Reconstruction of the intestinal lymphatic drainage after small bowel transplantation. Transplantation 2000;69(1):10–16.
   Google Scholar
• Meier D, Cagnola H, Ramisch D, Analysis of immune cells draining from the abdominal cavity as a novel tool to study intestinal transplant immunobiology. Clin Exp Immunol 2010;162(1):138–145.
   Google Scholar
• Bingaman AW, Farber DL. Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant 2004;4(6):846–852.
   Google Scholar
• Jones ND. Memory T cells: how might they disrupt the induction of tolerance? Transplantation 2009;87(9 Suppl):S74–S77.
   Google Scholar
• Hale DA. Biological effects of induction immunosuppression. Curr Opin Immunol 2004;16(5): 565–570.
   Google Scholar
• Tchao NK, Turka LA. Lymphodepletion and homeostatic proliferation: implications for transplantation. Am J Transplant 2012;12(5):1079–1090.
   PubMed Web of Science ®Google Scholar
• Neujahr DC, Chen C, Huang X, Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006;176(8):4632–4639.
   Google Scholar
• Pantenburg B, Heinzel F, Das L, T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol 2002;169(7):3686–3693.
   PubMed Web of Science ®Google Scholar
• Brehm MA, Markees TG, Daniels KA, Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 2003;170(8):4077–4086.
   PubMed Web of Science ®Google Scholar
• Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002;2(6):417–426.
   PubMed Web of Science ®Google Scholar
• Heeger PS, Greenspan NS, Kuhlenschmidt S, Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999;163(4):2267–2275.
   PubMed Web of Science ®Google Scholar
• Gondolesi G, Fauda M. Technical refinements in small bowel transplantation. Curr Opin Organ Transplant 2008;13(3):259–265.
   Google Scholar
• Pirenne J, Kawai M. Tolerogenic protocols for intestinal transplantation. Transpl Immunol 2004;13(2):131–137.
   Google Scholar
• Sudan DL, Chinnakotla S, Horslen S, Basiliximab decreases the incidence of acute rejection after intestinal transplantation. Transplant Proc 2002;34(3):940–941.
   Google Scholar
• Koshiba T, Kitade H, Waer M, Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation. Transplant Proc 2003;35(8):3153–3155.
   Google Scholar
• Kawai M, Kitade H, Mathieu C, Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 2005;79(9):1073–1077.
   Google Scholar
• Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001;1(3):233–239.
   Google Scholar
• Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci USA 2004;101(Suppl 2):14607–14614.
   Google Scholar
• Starzl TE. Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med. 2008;358(4):407–411.
   Google Scholar
• Leventhal J, Abecassis M, Miller J, Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012;4(124):124ra28.
   PubMed Web of Science ®Google Scholar
• Leventhal J, Abecassis M, Miller J, Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation 2013;95(1):169–176.
   PubMed Web of Science ®Google Scholar
• Scandling JD, Busque S, Dejbakhsh-Jones S, Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 2012;12(5):1133–1145.
   PubMed Web of Science ®Google Scholar
• Pirenne J, Kawai M. Tolerogenic protocol for intestinal transplantation. Transplant Proc 2006;38(6):1664–1667.
   Google Scholar
• Opelz G, Vanrenterghem Y, Kirste G, Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997;63(7):964–967.
   Google Scholar
• Gruessner RW, Nakhleh RE, Harmon JV, Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. Transplantation 1998;66(2):164–169.
   Google Scholar
• Dummer CD, Carpio VN, Goncalves LF, FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance. Transpl Immunol 2012;26(1):1–10.
   PubMed Web of Science ®Google Scholar
• Louis S, Braudeau C, Giral M, Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006;81(3):398–407.
   PubMed Web of Science ®Google Scholar
• Moreau A, Varey E, Bouchet-Delbos L, Cuturi MC. Cell therapy using tolerogenic dendritic cells in transplantation. Transplant Res 2012;1(1):13.
   Google Scholar
• Casiraghi F, Perico N, Remuzzi G. Mesenchymal stromal cells to promote solid organ transplantation tolerance. Curr Opin Organ Transplant 2013;18(1):51–58.
   Google Scholar
• Sun XJ, Li R, Sun X, Unique roles of Schistosoma japonicum protein Sj16 to induce IFN-gamma and IL-10 producing CD4(+)CD25(+) regulatory T cells in vitro and in vivo. Parasite Immunol 2012;34(8–9):430–439.
   Google Scholar